Suppr超能文献

Decrease in serum antibodies to SARS-CoV-2 in convalescent plasma donors over time.

作者信息

Prus Kristina, Alquist Caroline R, Cancelas Jose A, Oh David

机构信息

Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, USA.

出版信息

Transfusion. 2021 Feb;61(2):651-654. doi: 10.1111/trf.16172.

Abstract
摘要

相似文献

1
Decrease in serum antibodies to SARS-CoV-2 in convalescent plasma donors over time.
Transfusion. 2021 Feb;61(2):651-654. doi: 10.1111/trf.16172.
2
Convalescent blood plasma (CBP) donated by recovered COVID-19 patients - A comment.
Transfus Apher Sci. 2021 Jun;60(3):103108. doi: 10.1016/j.transci.2021.103108. Epub 2021 Mar 2.
3
Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors.
PLoS One. 2022 Feb 24;17(2):e0264124. doi: 10.1371/journal.pone.0264124. eCollection 2022.
6
Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.
Transfusion. 2021 Jun;61(6):1705-1709. doi: 10.1111/trf.16378. Epub 2021 Mar 22.
7
Detection of SARS-CoV-2-independent immunoregulatory activity of COVID-19 convalescent plasma.
Transfusion. 2021 Nov;61(11):3087-3093. doi: 10.1111/trf.16685. Epub 2021 Oct 8.
8
The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients.
Int Immunopharmacol. 2021 Feb;91:107325. doi: 10.1016/j.intimp.2020.107325. Epub 2020 Dec 24.
9
SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.
J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI148832.
10
Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines.
Transfus Med Rev. 2021 Jul;35(3):1-7. doi: 10.1016/j.tmrv.2021.07.001. Epub 2021 Jul 30.

引用本文的文献

1
COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination.
Microbiol Spectr. 2021 Dec 22;9(3):e0083021. doi: 10.1128/Spectrum.00830-21. Epub 2021 Dec 8.
2
Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.
PLoS One. 2021 Jul 14;16(7):e0254667. doi: 10.1371/journal.pone.0254667. eCollection 2021.

本文引用的文献

1
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.
Nat Med. 2020 Nov;26(11):1708-1713. doi: 10.1038/s41591-020-1088-9. Epub 2020 Sep 15.
2
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Cochrane Database Syst Rev. 2020 Jul 10;7(7):CD013600. doi: 10.1002/14651858.CD013600.pub2.
5
Characterization of source plasma from self-identified vaccinated or convalescent donors during the 2009 H1N1 pandemic.
Transfusion. 2018 May;58(5):1108-1116. doi: 10.1111/trf.14530. Epub 2018 Feb 15.
6
The use of convalescent plasma to treat emerging infectious diseases: focus on Ebola virus disease.
Curr Opin Hematol. 2015 Nov;22(6):521-6. doi: 10.1097/MOH.0000000000000191.
8
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.
Clin Infect Dis. 2011 Feb 15;52(4):447-56. doi: 10.1093/cid/ciq106. Epub 2011 Jan 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验